Chapter 5

Bottom line

MMR remains supportive, but its growth pulse has matured: FY26 sales fell 2% as launches fell 10% [1]. Sunteck's pre-sales rose 25% [2], ahead of Lodha's 11% MMR growth [3] but behind Rustomjee's 33% [4]. The evidence supports capable execution into premiumization, not a distinct moat.

From rebound to balance

The starting point was unusually favorable. In H1 2021, MMR sales rebounded 53% and unsold inventory fell 12% [5], while weighted-average prices remained 17% below their 2016 peak and Sunteck's annual report described affordability as being at a high [6]. That was a cyclical reset. By FY24, the region was already selling 90,314 homes [7], and Mumbai sales above ₹5 crore had doubled [8] to more than 3,000 units [9].

Sources: Sunteck FY2024 and FY2025 annual reports [10] [11]; Kolte-Patil FY2026 annual report [12].

FY25 extended the advance, but FY26 did not. Unit sales rose 7.8% in FY25 and then slipped 2.0%. The latest decline is modest, and supply adjusted faster: sales exceeded launches by 8,544 units in FY26, compared with 461 units in FY25. That is a constructive inventory setup rather than evidence of accelerating demand.

Sources: FY26 MMR sales and launches [13]; CY25 price and inventory metrics [14] [15].

Calendar 2025 provides the counterweight. Mumbai sales grew 1% [16] and launches fell 10% [17], while residential prices increased 7% [18]. Unsold stock still declined 6% to 155,604 units and quarters to sell remained 6.4 [19]. Supply discipline has kept the market balanced, but further price growth without volume growth would make affordability a restraint rather than a support.

Premiumization fits Sunteck

The market mix is favorable for Sunteck's existing positioning. In Q1 2026, homes priced between ₹1 crore and ₹3 crore represented 48% of Mumbai launches, while luxury and high-end homes contributed another 27%; the share below ₹50 lakh declined [20]. Sunteck's segment exposure is detailed in the Sunteck Primer; the portfolio leans into the same premiumization rather than waiting for a broad affordable-housing recovery.

The infrastructure fit is also direct. Metro Line 3 now links BKC, Worli, the airport and SEEPZ, while the Coastal Road and Atal Setu are operational; planned links extend connectivity toward western and peripheral nodes [21]. Those corridors overlap Sunteck's BKC, Goregaon, Mira Road, Vasai, Naigaon and Kalyan exposure [22]. Infrastructure can broaden the addressable market, but it benefits competing landowners and developers in the same micro-markets.

Execution without exclusivity

Sources: Sunteck FY2026 investor presentation [23]; Rustomjee Q4 FY2026 earnings call [24]; Lodha FY2026 annual report [25].

Sunteck outgrew regional unit sales and Lodha's much larger MMR business in FY26, but Rustomjee grew faster from a comparable MMR base. This supports a favorable execution read for the year, not a durable competitive advantage. The comparison excludes Oberoi Realty: its business overview reports annual RERA area sold and cumulative project sales values rather than a standardized annual pre-sales value [26].

Branded-developer consolidation is real but shared. Landowners, customers and lenders increasingly favor established operators, improving access to JDAs and finance [27]. The same conditions attract large, well-capitalized entrants and intensify competition for land and market share [28]. The corpus provides no comparable repeat-buyer, pricing-premium or project-level return series for Sunteck, so switching costs and brand economics are not established.

Decision markers

The constructive read holds if FY27 MMR sales remain broadly stable, quarters to sell stay near or below 6.4, and Sunteck continues to grow pre-sales faster than the regional market without sacrificing collections. A rise above eight quarters to sell alongside another volume decline would weaken the demand premise. Sustained Sunteck share gains across two years, coupled with better statutory cash conversion in Financial Trajectory, would be the evidence needed to move the competitive assessment beyond execution.